Redbiotec AG, a pioneer in living medicines, further expands its [...]
Redbiotec expands its Scientific Advisory Board with the appointment of Prof. Dr. Dr. Christoph U. Schoen
Redbiotec AG, a pioneer in living medicines, is pleased to [...]
Redbiotec welcomes two new senior people: Dr. Jin Huh, a [...]
Redbiotec is pleased to announce the appointment of Dr. Antonio [...]
Redbiotec is pleased to welcome Prof. Maries van den Broek, PhD, [...]
Big and growing interest in Redbiotec's COMOS and in Redbiotec's engineered bacteria carrying CRISPR. Redbiotec therefore further invests in its promising IO platforms.
Redbiotec is currently engineering and producing a number of novel bacteria strains to fight cancer.